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ABSTRACT 
 
OBJECTIVE: Temporal lobe epilepsy (TLE) is one of the most common forms of 
epilepsy. Unfortunately, the clinical outcomes of TLE cannot be determined based only 
on current diagnostic modalities. A better understanding of white matter (WM) 
connectivity changes in TLE may aid the identification of network abnormalities 
associated with TLE and the phenotypic characterization of the disease.  
 
METHODS: We implemented a novel approach for characterizing microstructural 
changes along WM pathways using diffusional kurtosis imaging (DKI). Along-the-tract 
measures were compared for 32 subjects with left TLE and 36 age- and gender-
matched controls along the left and right fimbria-fornix (FF), parahippocampal WM 
bundle (PWMB), arcuate fasciculus (AF), inferior longitudinal fasciculus (ILF), uncinate 
fasciculus, and cingulum bundle (CB). Limbic pathways were investigated in relation to 
seizure burden and control with anti-epileptic drugs.  
 
RESULTS: By evaluating measures along each tract, it was possible to identify 
abnormalities localized to specific tract sub-regions. Compared with healthy controls, 
subjects with TLE demonstrated pathological changes in circumscribed regions of the 
FF, PWMB, UF, AF and ILF. Several of these abnormalities were detected only by 
kurtosis-based and not by diffusivity-based measures. Structural WM changes 
correlated with seizure burden in the bilateral PWMB and cingulum.  
 CONCLUSIONS: DKI improves the characterization of network abnormalities 
associated with TLE by revealing connectivity abnormalities that are not disclosed by 
other modalities. Since TLE is a neuronal network disorder, DKI may be well suited to 
fully assess structural network abnormalities related to epilepsy and thus serve as a tool 
for phenotypic characterization of epilepsy. 
  
INTRODUCTION 
 
Temporal lobe epilepsy (TLE) is the most common form of medically intractable 
focal epilepsy and is frequently associated with hippocampal sclerosis (HS) (1). Despite 
that hippocampal pathology is generally considered the primary seizure generator and 
principal node in a temporal epileptiform network in TLE (2), there is a sizeable literature 
indicating that structural abnormalities extend beyond the medial temporal lobe. Many 
studies have reported gray matter atrophy, white matter (WM) loss, and gliosis affecting 
extra-hippocampal and extra-temporal regions (3-6). Crucially, the distribution of tissue 
damage in TLE is not random, but follows an anatomical and functional pattern whereby 
the most affected regions are those directly or indirectly associated with the medial 
temporal lobe and the limbic system (7-9). This regular distribution of damage implies 
that a limited number of common pathophysiological mechanisms are responsible for 
brain injury in TLE. In particular, gray matter loss may be caused by cellular excitoxicity 
along the limbic path of seizure spread, or by deafferentation injury from loss of neural 
connectivity (10). 
However, the full extent of microstructural brain damage in TLE is still 
incompletely understood, and most patients with TLE demonstrate some degree of 
extra-hippocampal abnormality (11). Importantly, seizure control after pharmacological 
and surgical intervention can vary significantly among patients with TLE, and there are 
clearly distinct phenotypes of TLE when it comes to treatment responsiveness. For this 
reason, it is fundamentally important to accurately assess in vivo patterns of brain injury 
in TLE, with special emphasis to cytoarchitectonic features of tissue damage and their 
anatomical distribution.  
 Previous studies have investigated alterations in WM pathways in TLE using 
diffusion tensor tractography (12-14). However, these studies predominantly utilize 
whole-tract analyses, which are limited as pathological changes may be concentrated in 
anatomically specific regions and whole-tract analyses may obstruct the detection of 
focal pathology. Moreover, diffusion tensor imaging (DTI) is incapable of detecting 
multiple, intra-voxel fiber bundle orientations in complex neurological tissue, which limits 
its potential for tractography (15,16). Diffusional kurtosis imaging (DKI) extends 
conventional DTI by estimating both the diffusion and kurtosis tensors to quantify 
restricted, non-Gaussian diffusion that occurs in biological tissues (17,18). Accordingly, 
DKI has demonstrated improved sensitivity for detecting neuropathology in a variety of 
conditions including epilepsy (19-22), stroke (23-26), Alzheimer’s disease (27-29), and 
numerous others. More recently, the advantages of DKI have been leveraged to provide 
more comprehensive assessment of diffusion in complex neural environments, including 
the characterization of diffusion anisotropy beyond the conventional fractional 
anisotropy (FA) (30) and computation of DKI-based WM tractography, enabling the 
resolution of multiple intra-voxel fiber bundles (16,31). These advantages are improved 
by utilizing DKI in conjunction with automated fiber quantification (AFQ) (32), for 
characterization of tissue microstructure along WM pathways, by incorporating a more 
comprehensive and potentially more sensitive collection of parameters for detecting 
disease-related pathology than does DTI. Thus, DKI is remarkably synergistic with AFQ, 
and the combination of the two form a particularly effective imaging method for 
detecting pathological WM changes. 
In this present study, we applied a novel neuroimaging approach combining the 
strengths of DKI and AFQ for the non-invasive characterization of pathological WM 
changes in TLE. We hypothesize that cytoarchitectural abnormalities follow a crescendo 
gradient towards the temporal lobe with pathological effects concentrated in particular 
WM regions, revealing patterns of neuroarchitectural pathology associated with TLE 
potentially underlying distinct phenotypical subtypes.  
 
METHODS 
 
Subjects 
This study was approved by the Institutional Review Board at the Medical 
University of South Carolina (MUSC). We evaluated data from 32 consecutive subjects 
with left TLE who were followed at the Comprehensive Epilepsy Center at MUSC. All 
subjects were diagnosed with left TLE in concordance with the diagnostic criteria 
proposed by the International League Against Epilepsy (ILAE), including a 
comprehensive medical history, a full neurological evaluation, and epileptiform 
discharges on interictal EEG, with the majority of subjects demonstrating 
neuroradiological evidence of HS (33). The mean (± std) age of all subjects was 44.8 (± 
16.7) years, and included 10 males and 22 females. A control group of 36 age and 
gender matched healthy individuals with no history of neurological problems was also 
recruited from the local community. Control subjects had a mean (± std) age of 40.4 (± 
11.6) years, including 12 males and 24 females. Clinical and demographic information 
for the subjects with TLE included in this study are further described in the table 
provided in the online supplemental material. The subjects included in this study are 
also described in a previous study from our group using voxel-based methods without 
tractography (22).  
Our cohort contained subjects with varying disease severity including subjects 
with recently diagnosed TLE and subjects whose seizures were well controlled with anti-
epileptic drugs (AEDs). Thus subjects in this cohort were not all surgical candidates. 
Subjects well controlled on AEDs were identified by having one or fewer seizures per 
six months (n = 13), and subjects not well controlled on AEDs were identified by having 
more than one seizure per six months (n = 19).    
 
Image Acquisition and Analysis 
Image acquisition was performed on a 3 Tesla Magnetom Verio MRI scanner 
(Siemens Medical, Erlangen, Germany) and included a DKI data set and T1-weighted 
images. DKI analysis included characterization of mean diffusivity (MD) and FA from the 
diffusion tensor and corresponding mean kurtosis (MK) and kurtosis fractional 
anisotropy (KFA) (30). DKI-derived tractography (16,31) was performed using 
diffusional kurtosis estimator software (https://www.nitrc.org/projects/dke/). DKI was 
incorporated into the AFQ image processing pipeline (https://github.com/jyeatman/AFQ) 
using fully automated in-house scripts, which included along-the-tract characterization 
of the fimbria-fornix (FF), parahippocampal white matter bundle (PWMB), arcuate 
fasciculus (AF), inferior longitudinal fasciculus (ILF), cingulum bundle (CB) and uncinate 
fasciculus (UF).  
The effects of seizure burden and seizure control with AEDs were tested in the 
PWMB and CB, as these limbic pathways are crucial for the progression of disease 
(12), neuropsychological manifestations of TLE (14), and differentiation of TLE subtypes 
by treatment response including surgical outcomes (34,35) and pharmacoresistance 
(36). Seizure burdfen was defined as equal to log$% 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦×𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛 , with the 
logarithm being applied to accommodate subjects with very high seizure frequency, and 
the effects were assessed using Pearson’s product-moment correlation coefficient. 
A summary of the image analysis steps for a single subject is given in Figure 1, 
and a detailed description of our image acquisition protocol and image analysis steps is 
given in the online supplemental material. 
  
Statistical Analysis 
 
Individual tract profiles were averaged over 5 regions of interest (ROIs), and a 
two sample t-test was performed to determine the significance of group-wise 
differences. Significance levels were corrected for multiple comparisons using the false 
discovery rate (FDR) procedure (37). For correlations with seizure burden, statistical 
significance was corrected for multiple comparisons with FDR, and the effects of 
pharmacoresistance were tested using the well-controlled and not well-controlled 
groups using a two sample t-test. Cohen’s d parameter was used to quantify the effect 
size. The ROIs used in this study are illustrated in Figure 2.  
 RESULTS 
 
Group-wise tract profiles for all fiber groups are shown in Figure 3. The tract 
profiles demonstrate similar along-the-tract variation of the diffusion metrics between 
subjects and controls and between the ipsilateral and contralateral hemispheres. 
Importantly, these results demonstrate that epilepsy-related abnormalities can be 
restricted to specific regions of each tract, which would be undetected by methods that 
group all data from one tract into a single value. The results in Figure 3 are tabulated in 
the online supplemental material.  
In general, MD is higher in subjects with TLE relative to controls in all ROIs and 
all fiber groups with the exception of one ipsilateral ROI (ROI 3 in the UF) and eight 
contralateral ROIs (ROI 1 and 5 in the FF, ROI 1 in the AF, ROI 2 and 3 in the UF, and 
ROIs 3-5 in the right ILF), although the observed changes were not found to be 
statistically significant. FA tended to be lower in subjects with TLE relative to controls, 
with statisitically significant reductions being found in ROIs 4 and 5 of the ipsilateral AF. 
 MK demonstrated significant reduction in the ipsilateral FF, PWMB, and UF in 
multiple ROIs. In the ipsilateral FF and UF, this reduction was more pronounced with 
increasing ROI number (further anteriorly within the temporal lobe). MK showed 
statistically significant reductions in all ROIs in the bilateral AF and ILF, except for ROI 1 
in the contralateral AF and ROI 3 in the contralateral ILF, with the ipsilateral side 
tending to demonstrate a stronger effect size.  
The location and relative significance of the observed differences are illustrated 
in the section-wise t-score plots in Figure 4. Qualitatively, the abnormal t-scores 
demonstrated a crescendo effect increasing in significance into the temporal lobe. 
Similar to the tract profiles, the section-wise t-score plots demonstrated a slight, but 
general increase in MD and decrease in FA in subjects relative to controls. With MK, the 
changes can be seen bilaterally, with the effect being the largest within the ipsilateral 
temporal lobe.  
Correlations with seizure burden are illustrated in Table 1. Significant correlations 
were found in the PWMB and CB with MD demonstrating significant correlations on the 
ipsilateral hemisphere and MK and KFA demonstrating bilateral limbic effects. In the 
ipsilateral PWMB, significant correlations were found for MD, MK, and KFA in ROI 3, 
with the correlations extending further along the tract anteriorly and posteriorly with MD 
and KFA. In the ipsilateral CB, significant correlations were found in ROI 5 for MD, ROIs 
2-5 for MK, and all ROIs for KFA. On the contralateral side, significant correlations with 
MK were found in ROI 3 of the PWMB and ROIs 2-5 of the CB, and with KFA in ROI 3 
and 4 of the PWMB and ROI 5 of the CB.  
Comparisons between AED responsive and unresponsive groups are illustrated 
in Table 2. Uncorrected p-values less than 0.05 were found in comparing subjects well-
controlled with AEDs with those poorly controlled for the ipsilateral PWMB in ROI 3 in 
MD and ROIs 3-4 in KFA and for the ipsilateral CB in ROI 5 in MD and all ROIs with the 
anisotropy parameters, FA and KFA. Uncorrected p-values less than 0.05 were also 
found for the contralateral CB in MK in ROI 2 and KFA in ROI 5. While none of these 
attained statistical significance following FDR correction, they may be indicative of 
trends that would warrant further investigation with a larger sample size. For example, 
the not well-controlled group demonstrated a 21% reduction in KFA in ROI 2 of the 
ipsilateral CB compared to the well-controlled group with a Cohen’s d parameter of -
1.262, suggesting a potentially large effect.  
 
DISCUSSION  
 
In this study, we employed a novel neuroimaging technique that combines DKI 
and AFQ for the in vivo characterization of cytoarchitectronic abnormalities in TLE along 
WM pathways which are physiologically relevant for TLE. In accordance with the 
previous literature, we detected pathological changes in several extra-hippocampal and 
extra-temporal WM tracts in subjects with TLE. Moreover, the important novel findings 
of this study pertain to the superior sensitivity of DKI-based tractography to identify and 
localize intra-pathway structural connectivity abnormalities in TLE. These observations 
complement our initial reports of increased sensitivity of DKI in scalar diffusion voxel-
based maps of subjects with epilepsy (22). This is the first study to use DKI-based 
tractography combined with AFQ, demonstrating how DKI tractography can overcome 
limitations imposed by fiber crossing and unveil epilepsy related abnormalities. Our data 
indicate that group-wise reductions in MK are observed in regionally specific areas of 
the ipsilateral FF, UF, and PWMB, as well as more diffuse bilateral abnormalities in the 
ILF and AF (Figure 3). We also report significant effects of seizure burden on MD, MK, 
and KFA of ipsilateral limbic pathways. MK and KFA indicated additional correlations 
with seizure burden in contralateral pathways (Table 1). The overall salience of these 
findings hinges on the technical innovations of these new forms of tractography and the 
critical need to better define phenotypic characterizations of subjects with epilepsy. 
 
Technical Innovations 
This is the first study to combine DKI and AFQ for the fully automated detection 
of cytoarchitectonic alterations along WM fiber pathways, which may be a particularly 
sensitive method for assessing WM tissue microstructure. With scalar, voxel-based 
data, it is not always clear which pathways are compromised. For example, an 
abnormal voxel in an ROI corresponding to the ILF may be related to transverse fibers 
in the same region. By defining which specific tracts are abnormal, one can develop a 
more detailed understanding of the distribution of cytoarchitectonic abnormalities. The 
methodological benefits of these approaches are further enhanced when augmented 
with along the tract measures, which not only identify the structurally compromised 
tracts, but additionally have the capability to localize specific abnormalities within the 
long axis of a tract. Moreover, the tract cores analyzed can preserve a significant 
amount of inter-subject anatomical tract variability while still enabling group-wise 
comparisons, which can help avoid normalization errors that complicate conventional 
voxel-wise techniques. This is further improved by utilizing DKI, which characterizes 
higher-order diffusion dynamics compared to DTI and can thus describe more complex 
diffusion profiles. Consequently, DKI enables the detection of crossing WM fiber 
bundles for diffusion tractography and provides a more comprehensive collection of 
quantitative parameters, which may enhance the detection of disease-related 
abnormalities. Thus, the combination of DKI and AFQ creates an effective tool for 
characterizing WM pathways, enabling further insights into patterns of 
neuroarchitectural pathology that occur in numerous neurological and psychiatric 
disorders.  
  
Towards a phenotypic microstructural connectivity characterization of TLE 
Increasingly, advanced neuroimaging techniques have demonstrated both 
localized and networked cytoarchitectonic abnormalities in TLE with limbic alterations 
potentially underlying various clinicopathological features of the disorder, including the 
pathological mechanisms that lead to medically intractable TLE (12), 
neuropsychological impairments (14), AED response (36), and surgical outcomes 
(34,35). In the present study, we recruited a cohort of 32 consecutive subjects 
diagnosed with left TLE, which was comprised of subjects with various disease 
severities. DKI in combination with AFQ detected pathological WM alterations 
consistent with our understanding of TLE as a network disease having tissue 
abnormalities concentrated in the temporal lobe of the brain. Moreover, statistical trends 
were observed in limbic structures between subjects whose seizures were well 
controled with AEDs and those who had worse AED control (Table 2), which could be 
an important clinical prognosticator. Interestingly, KFA in the ipsilateral PWMB and CB 
correlated with seizure burden, and we observed trends for differences in tract 
characteristics between subjects who had well-controlled seizures and those who did 
not, despite no detectible group-wise differences in this region with normal controls. A 
similar trend was seen between subjects who had well-controlled seizures with AEDs 
and those who did not in FA in the ipsilateral CB. A possible explanation for this is that 
distinct mechanisms may underlie AED response compared to pharmacoresistance, 
with AED responders having higher than normal diffusion anisotropy and subjects 
whose seizures were not well controlled having lower than normal diffusion anisotropy 
in these limbic structures. This also supports the need for the improved sensitivity in 
detecting patterns of neuroarchitectural alterations in TLE afforded by DKI. Moreover, 
DKI detected contralateral changes in MK that were not apparent in analysis of the 
conventional diffusivity-based parameters of MD and FA.  
This study also extends the work of Concha et al. (38), where along-the-tract 
measures were assessed in the ILF, AF, and UF using a manual segmentation routine 
with DTI in subjects with medically intractable TLE. In that work, it was argued that the 
changes in diffusion metrics could reflect astrogliosis and microstructural alterations 
related to the occurrence of seizures with potential effects of postictal vasogenic edema. 
In the present study, the reduction in MK reflects a net loss in the complexity of 
microstructural tissue compartmentalization, which is also consistent with subtle 
pathological denervation. By including a more comprehensive assessment of along-the-
tract diffusion abnormalities, the proposed technique may provide an important step 
towards a better understanding of the neuroarchitectural alterations that occur in TLE, 
as well as the development of fully automated imaging biomarkers for the separation of 
TLE subtypes based on clinically important distinctions.   
 Limitations  
 By focusing this study on tract profiles within the AFQ identified tract cores and 
using only a subset of the possible DKI-derived diffusion metrics, we have substantially 
restricted the scope of our analysis. This is a potential limitation of this study, as there 
may be important disease-related differences missed outside of the tract cores. 
Moreover, the quantitative parameters employed in this study depict physical properties 
of water diffusion which may be differentially influenced by multiple, distinct factors (15). 
To address this limitation DKI-based WM modeling techniques can be applied, which 
may improve the specificity of the observed changes (39). The subject cohort included 
in this study was comprised of individuals with left-sided TLE, as left- and right-sided 
TLE may have intrinsically different pathological effects on temporal lobe structures 
(40). Thus we were not able to assess the effects of right sided disease. In addition, this 
study was comprised of individuals with variying disease severity, including recently 
diagnosed and chronic TLE as well as individuals whose seizures were well-controlled 
and not well-controlled with AEDs. Well-controlled and intractable TLE may represent 
distinct pathological mechanisms; so by including both groups, sensitivity may be lost in 
characterizing regionally specific distinctions. Nevertheless, combining DKI with AFQ 
revealed distinct patterns of cytoarchitectronic abnormalities, which highlights the 
sensitivity as well as the potential applicability of the proposed techique.  
 
Conclusion  
There are measurable differences in WM tissue that are not routinely considered 
in the clinical assessment of subjects with unilateral TLE. We have described a diffusion 
MRI-based image analysis technique that, by combining the strengths of DKI and AFQ, 
can quantify cytoarchitectonic abnormalities in specific, WM fiber pathways. The 
proposed technique is shown to detect group-wise pathological changes, with the 
largest effect sizes lateralizing to the ipsilateral temporal lobe and extending along the 
tracts from the ipsilateral temporal lobe and including the contralateral side of the brain. 
Microstructural changes are also found to correlate with seizure burden in specific limbic 
pathways and trends are found towards detecting differences between subjects with 
well-controlled and not well-controlled TLE. Combining DKI and AFQ may be a 
particularly effective neuroimaging technique for detecting microstructural alterations 
along physiologically relevant WM pathways that could provide further insights into the 
variable clinical course of TLE, as well as a wide array of other neuropsychological 
conditions affecting the structural organization of the human brain.  
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FIGURE CAPTIONS 
 
Figure 1. AFQ with DKI. (A) DKI uses multiple diffusion weighting b-values and diffusion 
encoding directions to characterize non-Gaussian diffusion which occurs in vivo. The 
images shown include an average b=0 image along with images with diffusion 
weightings of b = 1000 and b = 2000 s/mm2 for a single diffusion-encoding direction. (B) 
Images in the DKI dataset are combined to estimate the diffusion tensor (DT) and 
kurtosis tensor (KT), which characterize the 3D intra-voxel diffusion dynamics based on 
physical properties of water diffusion. (C) The diffusion and kurtosis tensors are then 
analyzed to generate scalar, quantative parameter maps that can be used to 
characterize tissue microstructure. (D) The diffusion and kurtosis tensors are combined 
to perform DKI-based tractography, which can improve tractography relative to DTI by 
enabling the resolution of multiple intra-voxel fiber bundles in complex neural tissue. (E) 
AFQ performs a series of automated steps to segment fiber groups from standardized 
WM ROIs and then isolates each fiber group’s tract core for analysis of the diffusion 
parameters. Each subject generates tract profiles for each diffusion metric along each 
tract core, which can be compared to investigate individual and group-wise differences.  
 
Figure 2. The location of WM ROIs is defined from the reconstructed fiber tracts. The 
insert for each fiber group in the upper right-hand corner illustrates WM tracts identified 
by AFQ and DKI for a single subject, overlaid on the corresponding b=0 image. The 
solid black line indicates the core of each tract used in generating the individual tract 
profiles. Tract cores identified for all subjects in this study are averaged and overlaid on 
an anatomical MRI template to illustrate the group-wise representation of each fiber 
group. Each fiber group is divided into 5 ROIs with increasing ROI numbers indicating 
regionally-specific locations in each tract. The ROIs in this figure correspond to the 
ROIs used in the tables included in this study.  
 Figure 3. Mean tract profiles (± sem) for ipsilateral and contralateral fiber groups 
demonstrate regional group-wise differences in diffusion metrics between subjects and 
controls. Group-wise differences are tested over bins indicated by the green and purple 
bars and summary statistics for group-wise comparisons are given in the online 
supplemental material. Comparisons marked with an asterisk (*) have p-values < 0.05, 
and a double asterisk (**) indicates p-values < 0.005, after correction the significance 
level for multiple comparisons using FDR. The vertical bins correspond to the ROIs 
illustrated in Figure 2 with increasing ROI number corresponding to increasing Tract 
Section number. The MD is in units of μm2/ms, while the remaining parameters are 
dimensionless. 
 
 Figure 4. Section-wise t-score plots summarize the observed differences in the tract 
profiles. Section wise t-scores are calculated from the tract profiles illustrated in Figure 
3. These are overlaid on a WM template at positions indicated by the average of the 
tract-cores for all participants included in this study. Section-wise t-scores provide a 
visual representation of where pathological changes occur, with dark red indicating 
greater group-wise reductions in the subject versus control groups and dark blue 
indicating greater group-wise increases in the subjects versus control group.  
  
TABLES 
 
Parahippocampal	White	Matter	Bundle	
Param	 ROI	
Correlation	with	Seizure	Burden	 		
Left	 		 Right	 		
Pearson's	r	 p-value	 		 Pearson's	r	 p-value	 		
MD	
1	 0.272	 0.196	 		 0.310	 0.150	 		
2	 0.442	 0.038	 *	 0.279	 0.197	 		
3	 0.602	 0.007	 *	 0.342	 0.129	 		
4	 0.532	 0.017	 *	 0.386	 0.083	 		
5	 0.457	 0.036	 *	 0.277	 0.197	 		
FA	
1	 -0.122	 0.547	 		 -0.089	 0.665	 		
2	 -0.214	 0.304	 		 -0.166	 0.430	 		
3	 -0.246	 0.238	 		 -0.285	 0.192	 		
4	 -0.202	 0.329	 		 -0.130	 0.542	 		
5	 0.138	 0.502	 		 -0.190	 0.369	 		
MK	
1	 0.120	 0.549	 		 0.174	 0.408	 		
2	 0.325	 0.132	 		 0.204	 0.339	 		
3	 0.484	 0.027	 *	 0.436	 0.050	 *	
4	 0.397	 0.070	 		 0.396	 0.076	 		
5	 0.233	 0.262	 		 0.329	 0.142	 		
KFA	
1	 -0.258	 0.212	 		 -0.253	 0.236	 		
2	 -0.459	 0.036	 *	 -0.336	 0.135	 		
3	 -0.623	 0.006	 *	 -0.465	 0.035	 *	
4	 -0.564	 0.009	 *	 -0.452	 0.039	 *	
5	 -0.306	 0.148	 		 -0.313	 0.147	 		
		 		 		 		 		 		 		 		
Cingulum	Bundle	
Param	 ROI	
Correlation	with	Seizure	Burden	 		
Left	 		 Right	 		
Pearson's	r	 p-value	 		 Pearson's	r	 p-value	 		
MD	
1	 0.336	 0.126	 		 0.099	 0.622	 		
2	 0.314	 0.140	 		 0.187	 0.364	 		
3	 0.316	 0.138	 		 0.176	 0.390	 		
4	 0.386	 0.075	 *	 0.261	 0.209	 		
5	 0.446	 0.037	 *	 0.331	 0.132	 		
FA	
1	 -0.212	 0.305	 		 -0.060	 0.765	 		
2	 -0.284	 0.178	 		 -0.003	 0.986	 		
3	 -0.338	 0.127	 		 0.024	 0.908	 		
4	 -0.358	 0.098	 *	 -0.219	 0.296	 		
5	 -0.303	 0.150	 		 -0.390	 0.073	 I	
MK	
1	 0.415	 0.054	
	
0.394	 0.071	
	2	 0.518	 0.019	 *	 0.566	 0.010	 *	
3	 0.454	 0.035	 *	 0.592	 0.007	 *	
4	 0.456	 0.035	 *	 0.477	 0.029	 *	
5	 0.489	 0.026	 *	 0.504	 0.022	 *	
KFA	
1	 -0.465	 0.034	 *	 -0.317	 0.140	 		
2	 -0.498	 0.023	 *	 -0.366	 0.090	
	3	 -0.515	 0.019	 *	 -0.306	 0.150	 		
4	 -0.623	 0.011	 *	 -0.380	 0.078	
	5	 -0.582	 0.008	 *	 -0.525	 0.018	 *	
 
Table 1. Correlations with seizure burden for the PWMB and CB indicate limbic 
involvement in the progression of cytocarchitectural changes in TLE. ROI numbers 
correspond to the ROIs depicted in Figure 2, and statistically significant correlations are 
indicated by bold font and asterisks for p < 0.05 after FDR correction for multiple 
comparisons.  
 
 
  
Parahippocampal	White	Matter	Bundle	
		 		 Left	 		 Right	 		
Param	 ROI	 Control	 Patient	 Cohen's	d	 p-value	 		 Control	 Patient	 Cohen's	d	 p-value	 		
MD	
1	 1.29	(0.24)	 1.31	(0.41)	 0.037	 0.918	 		 1.33	(0.25)	 1.41	(0.36)	 0.260	 0.491	 		
2	 1.19	(0.17)	 1.28	(0.27)	 0.347	 0.343	 		 1.30	(0.18)	 1.37	(0.30)	 0.261	 0.489	 		
3	 1.08	(0.12)	 1.28	(0.28)	 0.894	 0.019	 		 1.17	(0.16)	 1.24	(0.24)	 0.347	 0.360	 		
4	 1.07	(0.13)	 1.27	(0.34)	 0.734	 0.050	 		 1.08	(0.15)	 1.12	(0.20)	 0.238	 0.529	 		
5	 1.12	(0.19)	 1.30	(0.34)	 0.655	 0.079	 		 1.11	(0.18)	 1.10	(0.20)	 -0.048	 0.898	 		
FA	
1	 0.16	(0.03)	 0.16	(0.04)	 -0.150	 0.680	 		 0.16	(0.04)	 0.15	(0.04)	 -0.228	 0.546	 		
2	 0.19	(0.02)	 0.18	(0.04)	 -0.386	 0.292	 		 0.18	(0.04)	 0.18	(0.04)	 -0.122	 0.745	 		
3	 0.20	(0.03)	 0.18	(0.04)	 -0.536	 0.147	 		 0.20	(0.04)	 0.19	(0.04)	 -0.384	 0.311	 		
4	 0.17	(0.04)	 0.15	(0.04)	 -0.539	 0.145	 		 0.20	(0.04)	 0.18	(0.03)	 -0.496	 0.194	 		
5	 0.12	(0.04)	 0.14	(0.04)	 0.337	 0.356	 		 0.16	(0.04)	 0.15	(0.04)	 -0.176	 0.641	 		
MK	
1	 0.75	(0.04)	 0.75	(0.07)	 -0.045	 0.902	 		 0.77	(0.04)	 0.78	(0.08)	 0.119	 0.752	 		
2	 0.75	(0.06)	 0.77	(0.06)	 0.190	 0.601	 		 0.79	(0.04)	 0.80	(0.06)	 0.210	 0.577	 		
3	 0.73	(0.10)	 0.76	(0.07)	 0.337	 0.357	 		 0.78	(0.05)	 0.81	(0.05)	 0.493	 0.196	 		
4	 0.69	(0.09)	 0.73	(0.09)	 0.446	 0.225	 		 0.75	(0.05)	 0.79	(0.09)	 0.443	 0.244	 		
5	 0.67	(0.11)	 0.72	(0.08)	 0.604	 0.104	 		 0.73	(0.06)	 0.75	(0.09)	 0.253	 0.503	 		
KFA	
1	 0.22	(0.08)	 0.23	(0.09)	 0.038	 0.916	 		 0.21	(0.09)	 0.19	(0.10)	 -0.233	 0.537	 		
2	 0.25	(0.08)	 0.23	(0.08)	 -0.293	 0.421	 		 0.22	(0.07)	 0.20	(0.08)	 -0.188	 0.617	 		
3	 0.30	(0.08)	 0.23	(0.09)	 -0.778	 0.039	 		 0.26	(0.07)	 0.23	(0.09)	 -0.362	 0.340	 		
4	 0.29	(0.09)	 0.22	(0.10)	 -0.739	 0.049	 		 0.31	(0.09)	 0.26	(0.09)	 -0.502	 0.189	 		
5	 0.24	(0.10)	 0.20	(0.08)	 -0.525	 0.155	 		 0.26	(0.08)	 0.26	(0.09)	 0.022	 0.952	 		
		 		 		 		 		 		 		 		 		 		 		 		
Cingulum	Bundle	
		 		 Left	 		 Right	 		
Param	 ROI	 Control	 Patient	 Cohen's	d	 p-value	 		 Control	 Patient	 Cohen's	d	 p-value	 		
MD	
1	 0.91	(0.06)	 0.96	(0.06)	 0.724	 0.053	 		 0.94	(0.08)	 0.95	(0.08)	 0.155	 0.669	 		
2	 0.88	(0.07)	 0.92	(0.08)	 0.646	 0.083	 		 0.90	(0.08)	 0.92	(0.07)	 0.296	 0.417	 		
3	 0.85	(0.06)	 0.89	(0.07)	 0.629	 0.091	 		 0.89	(0.09)	 0.90	(0.07)	 0.145	 0.690	 		
4	 0.85	(0.06)	 0.90	(0.09)	 0.668	 0.073	 		 0.87	(0.09)	 0.90	(0.10)	 0.329	 0.369	 		
5	 0.84	(0.05)	 0.89	(0.08)	 0.773	 0.040	 		 0.84	(0.07)	 0.90	(0.13)	 0.579	 0.118	 		
FA	
1	 0.21	(0.05)	 0.18	(0.04)	 -0.792	 0.036	 		 0.17	(0.04)	 0.16	(0.03)	 -0.261	 0.474	 		
2	 0.29	(0.06)	 0.23	(0.07)	 -1.032	 0.007	 		 0.22	(0.05)	 0.22	(0.05)	 -0.089	 0.807	 		
3	 0.36	(0.06)	 0.29	(0.06)	 -1.153	 0.003	 		 0.27	(0.07)	 0.27	(0.07)	 -0.047	 0.896	 		
4	 0.35	(0.05)	 0.31	(0.07)	 -0.790	 0.036	 		 0.30	(0.09)	 0.27	(0.06)	 -0.445	 0.226	 		
5	 0.31	(0.06)	 0.26	(0.06)	 -0.806	 0.033	 		 0.28	(0.08)	 0.23	(0.06)	 -0.628	 0.091	 		
MK	
1	 0.83	(0.07)	 0.85	(0.06)	 0.289	 0.428	 		 0.81	(0.08)	 0.83	(0.07)	 0.241	 0.507	 		
2	 0.83	(0.09)	 0.88	(0.09)	 0.511	 0.166	 		 0.81	(0.08)	 0.87	(0.09)	 0.752	 0.045	 		
3	 0.86	(0.13)	 0.91	(0.10)	 0.426	 0.246	 		 0.83	(0.10)	 0.90	(0.10)	 0.689	 0.065	 		
4	 0.87	(0.10)	 0.92	(0.09)	 0.502	 0.173	 		 0.84	(0.09)	 0.89	(0.10)	 0.534	 0.148	 		
5	 0.86	(0.12)	 0.90	(0.09)	 0.443	 0.228	 		 0.83	(0.10)	 0.89	(0.09)	 0.631	 0.090	 		
KFA	
1	 0.45	(0.08)	 0.37	(0.08)	 -1.031	 0.008	 		 0.38	(0.06)	 0.34	(0.08)	 -0.551	 0.136	 		
2	 0.57	(0.09)	 0.45	(0.10)	 -1.262	 0.001	 		 0.49	(0.10)	 0.42	(0.10)	 -0.594	 0.109	 		
3	 0.63	(0.10)	 0.53	(0.09)	 -1.102	 0.005	 		 0.53	(0.12)	 0.49	(0.10)	 -0.433	 0.239	 		
4	 0.59	(0.09)	 0.49	(0.10)	 -1.055	 0.006	 		 0.52	(0.13)	 0.47	(0.11)	 -0.437	 0.234	 		
5	 0.50	(0.11)	 0.40	(0.09)	 -0.927	 0.015	 		 0.46	(0.12)	 0.37	(0.11)	 -0.776	 0.039	 		
 
Table 2. Group-wise comparisons between subjects whose seizures are well-controlled 
with AEDs (n = 13) and subjects whose seizures are not well-controled by AEDs (n = 
19) in PWMB and CB pathways. Differences with p < 0.05 (uncorrected) are indicated 
by bold font. These may be regarded as trends, as no differences where significant after 
correcting for multiple comparisons.  
 
  
Online Supplemental Material: Image Acquisition and Data Analysis  
 
Image Acquisition 
 DKI datasets were acquired with a 3 Tesla Magnetom Verio MRI scanner 
(Siemens Medical, Erlangen, Germany) using a vendor-supplied, single-shot diffusion-
weighted EPI sequence with a twice-refocused spin echo (1) and a 12-channel head 
coil. To characterize non-Gaussian diffusion, the protocol included 3 diffusion 
weightings of b = 0, 1000, and 2000 s/mm2, with 30 isotropically distributed diffusion 
encoding directions and a total of 10 images with no diffusion weighting (b=0). Other 
acquisition parameters were: repetition time (TR) = 8500 ms, echo time (TE) = 98 ms, 
voxel dimensions = 3.0×3.0×3.0 mm3, matrix size × number of slices = 74×74×40, and a 
parallel imaging factor = 2 with no partial Fourier encoding. The acquisition time for this 
protocol was 9 minutes and 12 seconds. Structural imaging was also performed for 
each participant using a sagittal T1-weighted magnetization-prepared rapid acquisition 
gradient echo (MPRAGE) image sequence, with TR/TE = 2250/4.18 ms, inversion time 
= 900 ms, voxel dimensions = 1.0×1.0×1.0 mm3, and matrix size × number of slices = 
256×256×176.  
 
Image Analysis 
 DKI analysis included the estimation of the diffusion and kurtosis tensors (2) and 
subsequent DKI-derived tractography (3,4) and was performed using diffusional kurtosis 
estimator (DKE) software (https://www.nitrc.org/projects/dke/). Quantitative tensor 
analyses included characterization of mean diffusivity (MD) and FA from the diffusion 
tensor and corresponding mean kurtosis (MK) (2) and kurtosis fractional anisotropy 
(KFA) (5). DKI was incorporated into the AFQ image processing pipeline 
(https://github.com/jyeatman/AFQ) using fully automated in-house scripts written in 
MATLAB (MathWorks, Natick, MA, USA). 
 AFQ utilizes diffusion tractography data and performs a series of automated 
steps to identify and segment specific WM fiber bundles and isolate the core of each 
tract (6). Fiber bundles are selected by specifying regions of interest (ROIs) chosen 
from a WM template, which are applied to define the extremities of each tract. Once the 
core of a tract is identified, AFQ interpolates a fixed number of sections along the tract 
and estimates the diffusion and kurtosis tensors at every section, enabling 
reconstruction of all tensor-derived metrics. By using each subject’s unique tractography 
data, this approach can potentially accommodate more inter-subject variability in tract 
locations than alternative voxel-based methods. Tract profiles were excluded in cases 
where AFQ did not identify individual tracts (7).  
Beyond the conventional AFQ pipeline, we implemented in-house algorithms to 
automatically segment the fimbria-fornix (FF) WM fibers, in addition to the standard fiber 
groups used by AFQ. This was done as hippocampal sclerosis is a common 
pathological feature of TLE and the FF represents a major conduit of information to and 
from the hippocampus. Additional WM pathways were selected based on their 
hypothesized role in TLE, and include the parahippocampal white matter bundle 
(PWMB), arcuate fasciculus (AF), inferior longitudinal fasciculus (ILF), cingulum bundle 
(CB) and uncinate fasciculus (UF).  
 Tractography  
 DKI tractography was performed using the closed-form analytical expression of 
the kurtosis orientation distribution function derived by Jensen et al. (3) and the image 
analysis procedures developed by Glenn et al. (4) using the DKE tractography module 
(https://www.nitrc.org/projects/dke/). Whole brain masks were calculated within AFQ 
using FSL’s brain extraction tool, and DKI-based tractography was performed using the 
Euler method with an angle cutoff threshold of 35 degrees, a minimum tract length 
threshold of 20 mm, and 250,000 seed points randomly placed within each subject’s 
brain mask.  
 
Statistical Analysis 
Tract profiles were created for each fiber group using AFQ along 100 sections by 
interpolating the DKI-derived diffusion and kurtosis tensors along each tract and then 
quantifying the tensor-derived parameters for each section. Each tract was then divided 
into 5 regions of interest (ROIs), consisting of 20 consecutive sections. The respective 
along-the-tract diffusion metrics were averaged over each ROI and a two sample t-test 
was performed to determine the significance of group-wise differences. In all, there 
were a total of 12 fiber groups × 4 diffusion metrics × 5 regions of interest per fiber 
group, resulting in 240 total comparisons. Significance levels were corrected for multiple 
comparisons using the false discovery rate (FDR) procedure (8). To quantify the effect 
size of the observed changes, the Cohen’s d parameter was calculated for each ROI for 
group-wise differences as well as differences between subjects whose seizures were 
well-controlled with AEDs and those whose seizures were not well-controlled with 
AEDs. All group comparisons were unblinded.  
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Online Supplemental Material: Patient Demographic and Clinical Info 
 
Patient  
Number Gender 
Age 
(yr) 
Age of 
Epilepsy 
Onset (yr) 
Durration 
(yr) 
Seizure 
Frequency  
(per 6 Mo) 
MRI Results Interictal EEG 
1 F 57 52 5 3 Normal Left temporal IEDs 
2 F 57 35 22 24 Left HS Left temporal IEDs 
3 F 63 57 6 1 Normal Left temporal IEDs 
4 M 46 3 43 12 Left HS Left temporal IEDs 
5 M 56 30 26 6 Left HS Left temporal IEDs 
6 F 18 3 15 72 Left HS Left temporal IEDs 
7 F 37 33 4 6 Left HS Left temporal IEDs 
8 F 51 50 1 12 Normal Left temporal IEDs 
9 F 23 17 6 6 Left HS Left and right temporal IEDs 
10 M 22 10 12 0.5 Left HS Left temporal IEDs 
11 F 21 20 1 1 Left HS Left temporal IEDs 
12 M 34 15 19 1 Normal Left temporal IEDs 
13 F 58 55 3 1 Left HS Left temporal IEDs 
14 M 20 20 0 0.2 Left HS Left and right temporal IEDs 
15 F 67 66 1 6 Normal Left temporal IEDs 
16 F 62 62 0 0.2 Left HS Left temporal IEDs 
17 F 57 1 56 2 Left HS Normal 
18 F 18 5 13 3 Left HS Left temporal IEDs 
19 F 37 28 9 2 Left HS Normal 
20 F 20 19 1 1 Left HS Normal 
21 F 57 50 7 6 Left HS Left and right temporal IEDs 
22 F 45 33 12 2 Left HS Normal 
23 M 43 0 43 3 Left HS Normal 
24 F 76 30 46 6 Left HS Left temporal IEDs 
25 M 36 17 19 1 Left HS Normal 
26 M 65 59 6 1 Left HS Normal 
27 F 57 2 55 6 Left HS Left temporal IEDs 
28 M 45 27 18 2 Left HS Normal 
29 F 27 27 0 0.2 Left HS Normal 
30 F 59 42 17 3 Left HS Left temporal IEDs 
31 F 46 35 11 0.5 Left HS Left temporal IEDs 
32 M 40 37 3 0.2 Left HS Normal 
 Note: HS, hippocampal sclerosis; EEG, electroencephalography; IED, interictal 
epileptiform discharges; in cases where left and right IEDs were noted, left IEDs were 
greater than right IEDs and signs of unilateral left HS were present on MRI 
  
Online Supplemental Material: Tract Profile Summary Statistics  
 
Fimbria-Fornix 
    Left     Right   
Param ROI Control Patient 
Cohen's 
d 
p-
value     Control Patient 
Cohen's 
d 
p-
value   
MD 
1 1.81 (0.34) 1.98 (0.46) -0.423 0.332     1.99 (0.37) 1.98 (0.52) 0.014 0.976   
2 1.91 (0.34) 2.05 (0.40) -0.378 0.407     1.97 (0.42) 2.04 (0.45) -0.174 0.744   
3 1.22 (0.25) 1.37 (0.39) -0.453 0.283     1.24 (0.22) 1.30 (0.34) -0.241 0.631   
4 1.27 (0.18) 1.40 (0.31) -0.504 0.212     1.28 (0.17) 1.30 (0.23) -0.117 0.832   
5 1.15 (0.18) 1.23 (0.25) -0.357 0.426     1.29 (0.28) 1.22 (0.24) 0.286 0.565   
FA 
1 0.20 (0.04) 0.19 (0.05) 0.419 0.338     0.19 (0.04) 0.18 (0.05) 0.115 0.829   
2 0.18 (0.05) 0.16 (0.04) 0.317 0.510     0.17 (0.04) 0.16 (0.04) 0.261 0.589   
3 0.28 (0.07) 0.26 (0.07) 0.268 0.594     0.28 (0.06) 0.25 (0.06) 0.460 0.276   
4 0.24 (0.04) 0.22 (0.05) 0.343 0.448     0.24 (0.05) 0.23 (0.05) 0.268 0.593   
5 0.21 (0.04) 0.19 (0.07) 0.250 0.619     0.20 (0.05) 0.20 (0.05) 0.110 0.822   
MK 
1 0.71 (0.08) 0.66 (0.09) 0.590 0.116     0.68 (0.08) 0.68 (0.10) 0.068 0.920   
2 0.69 (0.08) 0.65 (0.08) 0.435 0.311     0.68 (0.09) 0.65 (0.09) 0.242 0.630   
3 0.82 (0.06) 0.77 (0.09) 0.695 0.055     0.83 (0.07) 0.79 (0.09) 0.395 0.388   
4 0.80 (0.06) 0.74 (0.07) 0.997 < 0.005 **   0.81 (0.05) 0.78 (0.06) 0.514 0.194   
5 0.79 (0.05) 0.72 (0.07) 1.220 < 0.005 **   0.78 (0.06) 0.75 (0.09) 0.447 0.281   
KFA 
1 0.15 (0.04) 0.16 (0.09) -0.156 0.772     0.14 (0.04) 0.15 (0.06) -0.255 0.603   
2 0.13 (0.04) 0.13 (0.04) 0.094 0.877     0.14 (0.04) 0.14 (0.05) 0.051 0.930   
3 0.30 (0.10) 0.27 (0.11) 0.236 0.622     0.28 (0.08) 0.26 (0.08) 0.177 0.745   
4 0.25 (0.06) 0.23 (0.07) 0.241 0.628     0.23 (0.06) 0.24 (0.08) -0.160 0.765   
5 0.25 (0.07) 0.24 (0.08) 0.052 0.932     0.23 (0.08) 0.23 (0.08) -0.093 0.882   
 
Parahippocampal White Matter Bundle 
    Left     Right   
Param ROI Control Patient Cohen's d p-value     Control Patient Cohen's d p-value   
MD 
1 1.25 (0.29) 1.30 (0.34) -0.168 0.753     1.26 (0.28) 1.38 (0.32) -0.397 0.383   
2 1.23 (0.21) 1.24 (0.24) -0.066 0.922     1.28 (0.20) 1.34 (0.26) -0.286 0.571   
3 1.18 (0.18) 1.20 (0.25) -0.091 0.872     1.20 (0.16) 1.21 (0.21) -0.058 0.929   
4 1.14 (0.18) 1.19 (0.29) -0.225 0.633     1.08 (0.13) 1.10 (0.18) -0.138 0.790   
5 1.14 (0.19) 1.23 (0.30) -0.379 0.400     1.06 (0.15) 1.11 (0.19) -0.274 0.589   
FA 
1 0.18 (0.05) 0.16 (0.03) 0.484 0.229     0.17 (0.05) 0.15 (0.04) 0.362 0.432   
2 0.20 (0.05) 0.18 (0.03) 0.448 0.288     0.18 (0.04) 0.18 (0.04) 0.091 0.874   
3 0.20 (0.04) 0.18 (0.03) 0.361 0.420     0.20 (0.04) 0.20 (0.04) -0.015 0.980   
4 0.18 (0.03) 0.16 (0.04) 0.620 0.092     0.19 (0.04) 0.19 (0.04) 0.087 0.880   
5 0.15 (0.03) 0.13 (0.04) 0.479 0.234     0.15 (0.03) 0.16 (0.04) -0.014 0.980   
MK 
1 0.79 (0.06) 0.75 (0.06) 0.659 0.066     0.80 (0.05) 0.77 (0.06) 0.511 0.205   
2 0.80 (0.05) 0.76 (0.06) 0.810 0.018 *   0.82 (0.04) 0.79 (0.05) 0.608 0.108   
3 0.79 (0.05) 0.74 (0.08) 0.668 0.064     0.81 (0.04) 0.80 (0.05) 0.311 0.520   
4 0.76 (0.07) 0.72 (0.09) 0.565 0.127     0.76 (0.08) 0.77 (0.08) -0.196 0.712   
5 0.75 (0.05) 0.70 (0.10) 0.708 0.045 *   0.74 (0.09) 0.74 (0.08) -0.040 0.947   
KFA 
1 1.26 (0.28) 1.38 (0.32) -0.397 0.383     0.21 (0.09) 0.20 (0.09) 0.127 0.811   
2 1.28 (0.20) 1.34 (0.26) -0.286 0.571     0.20 (0.07) 0.21 (0.08) -0.036 0.949   
3 1.20 (0.16) 1.21 (0.21) -0.058 0.929     0.24 (0.08) 0.24 (0.08) -0.090 0.874   
4 1.08 (0.13) 1.10 (0.18) -0.138 0.790     0.29 (0.11) 0.28 (0.09) 0.058 0.931   
5 1.06 (0.15) 1.11 (0.19) -0.274 0.589     0.28 (0.10) 0.26 (0.09) 0.200 0.709   
 
Note: ROI locations correspond to those illustrated in Figure 2. Control and Patient 
values represent mean (± sandard deviation). Statistically significant differences are 
indicated by bold font and with a single asterisk for p < 0.05 and a double asterisk for p 
< 0.005, after correcting for multiple comparisons with FDR. 
 
Arcuate Fasciculus  
    Left     Right   
Param ROI Control Patient Cohen's d p-value     Control Patient Cohen's d p-value   
MD 
1 0.80 (0.02) 0.80 (0.05) -0.111 0.821     0.80 (0.03) 0.80 (0.05) 0.026 0.969   
2 0.82 (0.03) 0.83 (0.05) -0.237 0.625     0.83 (0.04) 0.83 (0.05) -0.113 0.826   
3 0.84 (0.03) 0.85 (0.06) -0.279 0.572     0.85 (0.03) 0.86 (0.06) -0.170 0.750   
4 0.86 (0.03) 0.89 (0.06) -0.444 0.284     0.88 (0.04) 0.89 (0.07) -0.320 0.490   
5 0.88 (0.04) 0.89 (0.06) -0.340 0.445     0.88 (0.04) 0.88 (0.06) -0.018 0.979   
FA 
1 0.36 (0.05) 0.35 (0.06) 0.173 0.746     0.33 (0.06) 0.33 (0.08) -0.069 0.923   
2 0.34 (0.06) 0.33 (0.05) 0.164 0.752     0.33 (0.07) 0.34 (0.06) -0.123 0.811   
3 0.37 (0.06) 0.36 (0.07) 0.167 0.751     0.38 (0.06) 0.37 (0.05) 0.142 0.793   
4 0.31 (0.06) 0.28 (0.05) 0.763 0.026 *   0.29 (0.06) 0.28 (0.05) 0.029 0.961   
5 0.41 (0.06) 0.35 (0.04) 1.118 < 0.005 **   0.41 (0.06) 0.40 (0.06) 0.145 0.785   
MK 
1 1.20 (0.06) 1.15 (0.08) 0.830 0.016 *   1.19 (0.06) 1.14 (0.10) 0.621 0.094   
2 1.18 (0.06) 1.11 (0.08) 0.946 < 0.005 **   1.16 (0.06) 1.10 (0.09) 0.726 0.038 * 
3 1.14 (0.05) 1.07 (0.08) 1.210 < 0.005 **   1.13 (0.06) 1.06 (0.09) 0.963 < 0.005 ** 
4 1.11 (0.05) 1.03 (0.08) 1.360 < 0.005 **   1.10 (0.06) 1.03 (0.09) 0.960 < 0.005 ** 
5 1.09 (0.05) 1.02 (0.09) 0.936 < 0.005 **   1.08 (0.06) 1.03 (0.09) 0.746 0.031 * 
KFA 
1 0.54 (0.04) 0.55 (0.07) -0.236 0.625     0.52 (0.04) 0.53 (0.08) -0.263 0.587   
2 0.53 (0.04) 0.54 (0.07) -0.225 0.641     0.54 (0.04) 0.56 (0.08) -0.225 0.638   
3 0.53 (0.05) 0.53 (0.08) 0.023 0.971     0.52 (0.05) 0.52 (0.07) 0.001 0.997   
4 0.42 (0.05) 0.39 (0.07) 0.440 0.284     0.37 (0.06) 0.38 (0.07) -0.162 0.758   
5 0.45 (0.06) 0.42 (0.07) 0.476 0.236     0.42 (0.06) 0.43 (0.09) -0.180 0.748   
 
Inferior Longitudinal Fasciculus 
    Left     Right   
Param ROI Control Patient Cohen's d p-value     Control Patient Cohen's d p-value   
MD 
1 0.97 (0.10) 1.00 (0.12) -0.309 0.514     0.96 (0.09) 0.97 (0.13) -0.112 0.821   
2 0.96 (0.09) 0.98 (0.08) -0.288 0.569     0.97 (0.08) 0.98 (0.09) -0.052 0.932   
3 0.96 (0.06) 1.00 (0.08) -0.556 0.135     1.00 (0.07) 0.99 (0.09) 0.164 0.756   
4 0.96 (0.06) 0.99 (0.10) -0.362 0.422     1.00 (0.07) 0.99 (0.10) 0.180 0.745   
5 0.99 (0.09) 1.04 (0.18) -0.375 0.409     0.99 (0.11) 0.98 (0.12) 0.044 0.949   
FA 
1 0.43 (0.10) 0.42 (0.06) 0.136 0.793     0.40 (0.05) 0.39 (0.05) 0.321 0.494   
2 0.41 (0.08) 0.39 (0.06) 0.287 0.562     0.37 (0.05) 0.37 (0.05) 0.145 0.789   
3 0.33 (0.07) 0.31 (0.06) 0.420 0.328     0.29 (0.06) 0.30 (0.05) -0.176 0.749   
4 0.25 (0.06) 0.24 (0.06) 0.260 0.591     0.23 (0.06) 0.22 (0.05) 0.135 0.787   
5 0.18 (0.07) 0.16 (0.05) 0.370 0.409     0.17 (0.06) 0.16 (0.06) 0.158 0.761   
MK 
1 0.98 (0.08) 0.92 (0.09) 0.793 0.021 *   1.00 (0.06) 0.92 (0.09) 1.091 < 0.005 ** 
2 0.96 (0.06) 0.88 (0.09) 0.968 < 0.005 **   0.96 (0.05) 0.90 (0.08) 0.902 0.007 * 
3 0.93 (0.06) 0.86 (0.09) 0.874 0.010 *   0.90 (0.06) 0.86 (0.06) 0.582 0.116   
4 0.88 (0.06) 0.82 (0.08) 0.981 < 0.005 **   0.87 (0.06) 0.82 (0.05) 0.812 0.018 * 
5 0.83 (0.07) 0.76 (0.08) 1.002 < 0.005 **   0.83 (0.05) 0.76 (0.11) 0.782 0.023 * 
KFA 
1 0.41 (0.10) 0.42 (0.08) -0.070 0.924     0.38 (0.06) 0.41 (0.09) -0.379 0.405   
2 0.39 (0.08) 0.39 (0.09) -0.018 0.975     0.34 (0.07) 0.37 (0.09) -0.341 0.445   
3 0.35 (0.08) 0.34 (0.08) 0.138 0.798     0.28 (0.06) 0.33 (0.09) -0.663 0.065   
4 0.28 (0.07) 0.29 (0.09) -0.057 0.925     0.25 (0.05) 0.27 (0.07) -0.352 0.431   
5 0.22 (0.09) 0.22 (0.09) 0.076 0.907     0.22 (0.08) 0.24 (0.11) -0.174 0.748   
 
Note: ROI locations correspond to those illustrated in Figure 2. Control and Patient 
values represent mean (± sandard deviation). Statistically significant differences are 
indicated by bold font and with a single asterisk for p < 0.05 and a double asterisk for p 
< 0.005, after correcting for multiple comparisons with FDR. 
  
Cingulum Bundle 
    Left     Right   
Param ROI Control Patient Cohen's d 
p-
value     Control Patient Cohen's d 
p-
value   
MD 
1 0.93 (0.05) 0.94 (0.06) -0.136 0.797     0.91 (0.05) 0.95 (0.08) -0.591 0.112   
2 0.89 (0.05) 0.91 (0.08) -0.303 0.525     0.89 (0.05) 0.91 (0.08) -0.266 0.589   
3 0.86 (0.04) 0.88 (0.07) -0.297 0.541     0.88 (0.06) 0.90 (0.08) -0.205 0.679   
4 0.87 (0.04) 0.88 (0.08) -0.288 0.564     0.89 (0.06) 0.89 (0.10) -0.059 0.928   
5 0.85 (0.03) 0.87 (0.07) -0.354 0.429     0.86 (0.04) 0.88 (0.11) -0.210 0.668   
FA 
1 0.20 (0.05) 0.19 (0.05) 0.155 0.770     0.19 (0.04) 0.17 (0.03) 0.648 0.072   
2 0.26 (0.06) 0.26 (0.07) 0.003 0.996     0.23 (0.04) 0.22 (0.05) 0.257 0.595   
3 0.31 (0.05) 0.32 (0.07) -0.133 0.789     0.27 (0.05) 0.27 (0.07) -0.040 0.951   
4 0.33 (0.05) 0.33 (0.07) 0.068 0.924     0.27 (0.05) 0.28 (0.07) -0.191 0.714   
5 0.29 (0.05) 0.28 (0.06) 0.141 0.793     0.24 (0.06) 0.25 (0.07) -0.136 0.801   
MK 
1 0.87 (0.06) 0.84 (0.07) 0.374 0.407     0.87 (0.06) 0.82 (0.07) 0.696 0.050 * 
2 0.89 (0.07) 0.86 (0.09) 0.355 0.431     0.88 (0.07) 0.85 (0.09) 0.392 0.383   
3 0.94 (0.06) 0.89 (0.11) 0.588 0.112     0.90 (0.07) 0.87 (0.11) 0.368 0.409   
4 0.94 (0.07) 0.90 (0.10) 0.551 0.139     0.91 (0.06) 0.87 (0.09) 0.518 0.184   
5 0.93 (0.06) 0.88 (0.10) 0.614 0.095     0.90 (0.05) 0.87 (0.10) 0.448 0.284   
KFA 
1 0.41 (0.07) 0.40 (0.09) 0.152 0.771     0.40 (0.07) 0.36 (0.07) 0.533 0.163   
2 0.51 (0.08) 0.50 (0.11) 0.024 0.970     0.47 (0.07) 0.45 (0.11) 0.234 0.622   
3 0.56 (0.07) 0.57 (0.11) -0.078 0.904     0.52 (0.08) 0.51 (0.11) 0.115 0.832   
4 0.53 (0.06) 0.53 (0.11) 0.003 0.998     0.47 (0.08) 0.49 (0.12) -0.181 0.749   
5 0.41 (0.06) 0.44 (0.11) -0.349 0.430     0.40 (0.08) 0.41 (0.12) -0.114 0.828   
 
Uncinate Fasciculus 
    Left     Right   
Param ROI Control Patient Cohen's d p-value     Control Patient Cohen's d p-value   
MD 
1 0.96 (0.08) 0.97 (0.14) -0.023 0.970     0.93 (0.12) 0.94 (0.10) -0.135 0.806   
2 0.96 (0.16) 0.96 (0.17) -0.007 0.990     0.95 (0.17) 0.94 (0.10) 0.066 0.919   
3 1.03 (0.24) 1.02 (0.19) 0.042 0.945     0.99 (0.22) 0.98 (0.09) 0.068 0.923   
4 1.04 (0.23) 1.07 (0.27) -0.100 0.875     1.01 (0.26) 1.03 (0.13) -0.067 0.920   
5 1.05 (0.18) 1.10 (0.26) -0.239 0.637     1.03 (0.26) 1.13 (0.28) -0.366 0.432   
FA 
1 0.25 (0.09) 0.26 (0.08) -0.039 0.951     0.29 (0.09) 0.27 (0.09) 0.288 0.578   
2 0.27 (0.08) 0.27 (0.09) -0.038 0.946     0.28 (0.08) 0.26 (0.07) 0.236 0.633   
3 0.26 (0.09) 0.26 (0.09) -0.044 0.952     0.28 (0.08) 0.26 (0.08) 0.207 0.706   
4 0.25 (0.08) 0.23 (0.08) 0.241 0.635     0.27 (0.08) 0.24 (0.07) 0.430 0.348   
5 0.20 (0.07) 0.18 (0.07) 0.302 0.572     0.24 (0.06) 0.20 (0.08) 0.608 0.119   
MK 
1 0.78 (0.05) 0.74 (0.07) 0.622 0.123     0.77 (0.06) 0.75 (0.10) 0.248 0.623   
2 0.80 (0.06) 0.76 (0.10) 0.533 0.222     0.78 (0.06) 0.76 (0.09) 0.255 0.632   
3 0.80 (0.05) 0.76 (0.09) 0.654 0.109     0.79 (0.08) 0.77 (0.08) 0.278 0.591   
4 0.81 (0.05) 0.74 (0.12) 0.851 0.023 *   0.80 (0.07) 0.77 (0.09) 0.300 0.568   
5 0.81 (0.05) 0.74 (0.10) 0.945 0.011 *   0.81 (0.06) 0.78 (0.08) 0.476 0.286   
KFA 
1 0.34 (0.12) 0.36 (0.12) -0.161 0.784     0.42 (0.13) 0.37 (0.12) 0.404 0.400   
2 0.33 (0.12) 0.36 (0.13) -0.297 0.583     0.35 (0.12) 0.32 (0.10) 0.333 0.502   
3 0.26 (0.11) 0.29 (0.11) -0.274 0.601     0.29 (0.10) 0.29 (0.11) -0.045 0.948   
4 0.26 (0.10) 0.29 (0.13) -0.259 0.629     0.28 (0.11) 0.27 (0.10) 0.132 0.808   
5 0.23 (0.08) 0.25 (0.12) -0.194 0.747     0.26 (0.09) 0.23 (0.09) 0.339 0.498   
 
Note: ROI locations correspond to those illustrated in Figure 2. Control and Patient 
values represent mean (± sandard deviation). Statistically significant differences are 
indicated by bold font and with a single asterisk for p < 0.05 and a double asterisk for p 
< 0.005, after correcting for multiple comparisons with FDR. 
 
